Effect of the phospholipase A2 inhibitor Varespladib, and its synergism with crotalic antivenom, on the neuromuscular blockade induced by Crotalus durissus terrificus venom (with and without crotamine) in mouse neuromuscular preparations

The venom of the South American rattlesnake Crotalus durissus terrificus causes an irreversible neuromuscular blockade in isolated preparations due to action of the presynaptically-acting heterodimeric phospholipase A2 (PLA2) crotoxin. Some populations of this subspecies contain, in addition to crot...

Full description

Saved in:
Bibliographic Details
Published in:Toxicon (Oxford) 2022-07, Vol.214, p.54-61
Main Authors: de Souza, Jocimar, Oliveira, Isadora C.F., Yoshida, Edson H., Cantuaria, Nathalia M., Cogo, José C., Torres-Bonilla, Kristian A., Hyslop, Stephen, Silva Junior, Nelson J., Floriano, Rafael S., Gutiérrez, José María, Oshima-Franco, Yoko
Format: Article
Language:English
Subjects:
Crotalic antivenom
Crotalus durissus terrificus Venom
Myographic technique
Neuromuscular preparation
Varespladib
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The venom of the South American rattlesnake Crotalus durissus terrificus causes an irreversible neuromuscular blockade in isolated preparations due to action of the presynaptically-acting heterodimeric phospholipase A2 (PLA2) crotoxin. Some populations of this subspecies contain, in addition to crotoxin, the toxin crotamine, which acts directly on muscle fibers. In this study we used C. d. terrificus venoms with (crot+) or without (crot-) crotamine to test whether Varespladib, a PLA2 inhibitor, is able to abrogate the neuromuscular blockade induced by these venoms comparatively with crotalic antivenom. Mouse phrenic nerve-diaphragm preparations were exposed to venoms previously incubated with two different concentrations of Varepladib or antivenom, or with a mixture of these two agents, before addition to the bath. In another experimental setting, venoms were initially added to the system, followed by the addition of Varespladib or antivenom 10, 30, or 60 min after venom. At the highest concentrations tested, Varespladib and antivenom inhibited the action of the venom >80% and >70%, respectively. With lower concentrations the inhibition of neuromuscular blockade decreased, but when low doses of the two agents were incubated together with the venom, the inhibitory effect improved, underscoring a synergistic phenomenon. When added after venom, Varespladib was able to halt the progression of the neuromuscular blockade even when added at 60 min. Antivenom exhibited a lower ability to inhibit the toxic effect of the venoms in these conditions. In conclusion, the PLA2 inhibitor Varespladib is highly effective at abrogating the neuromuscular blocking activity of crotamine-positive and crotamine-negative C. d. terrificus venoms and seems to act synergistically with antivenom. [Display omitted] •Crotalus durissus terrificus venom induces blockade of neuromuscular preparations.•Varespladib and crotalic antivenom abrogate the effect when preincubated with venom.•Varespladib and antivenom act synergistically in venom inhibition.•If added after venom, Varespladib inhibited neuromuscular blockade more effectively than antivenom.
ISSN:0041-0101
1879-3150
DOI:10.1016/j.toxicon.2022.05.001